GDUFA Research Outcomes
Topical Products
This section contains scientific publications, presentations, and posters arising from GDUFA-funded research relevant to locally acting generic products administered via the topical route, including topical dermatological products.
-
Beyond the API: Role of Formulation in Topical Product Development
Ghosh, Priyanka
-
Advancing In Silico Methods and Future Opportunities for Understanding Impact of Compositional Differences on Performance
Walenga, Ross
-
FDA’s Role in Regulating Products for Dermatology, Including Drugs, Biologics, Devices, and Cosmetics – With a Special Focus on Generic Drugs
Luke, Markham
-
FDA’s Role in Regulating Products for Dermatology, Including Drugs, Biologics, Devices, and Cosmetics – With a Special Focus on Generic Drugs
Luke, Markham
-
Development of FDA’s Guidance for Industry on IVPT Studies for Topical Drug Products Submitted in ANDAs
Raney, Sam G.
-
In Vitro Permeation Testing (IVPT)
Luke, Markham
-
Navigating Formulation Assessment: Considerations for Products that are Not Required to be Q1Q2
Jiang, Ying
-
Current Status and Outstanding Challenges IVPT Studies
Ghosh, Priyanka
-
Impact of Cream Composition on Critical Quality Attributes of Miconazole Nitrate Vaginal Creams
Xu, Zizhao; Zhou, Chenfei; Desai, Krisha Hardik; Kelchen, Megan; Xie, Lingxiao; Ghosh, Priyanka; Shen, Jie
-
Sensory Panel Tests for Topical Semi-Solid Creams: Correlation Between Sensorial Perceptions and Product Critical Quality Attributes
Phan, Khanh; Leite-Silva, Vania R; Prakash, Sangeeta; Liu, David; Ramezanli, Tannaz; Ghosh, Priyanka; Raney, Sam G; Luke, Markham; Roberts, Michael; Mohammed, Yousuf